164 related articles for article (PubMed ID: 8265768)
1. The use of herpes simplex virus vectors for gene therapy in neurological diseases.
Kennedy PG; Steiner I
Q J Med; 1993 Nov; 86(11):697-702. PubMed ID: 8265768
[TBL] [Abstract][Full Text] [Related]
2. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
Geller AI; Yu L; Wang Y; Fraefel C
Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
[TBL] [Abstract][Full Text] [Related]
3. [Advance of gene therapy for neurological diseases by direct in vivo gene transfer].
Li BY; Liu C; Wang HX
Sheng Li Ke Xue Jin Zhan; 1996 Jul; 27(3):215-20. PubMed ID: 9772359
[TBL] [Abstract][Full Text] [Related]
4. HSV trafficking and development of gene therapy vectors with applications in the nervous system.
Frampton AR; Goins WF; Nakano K; Burton EA; Glorioso JC
Gene Ther; 2005 Jun; 12(11):891-901. PubMed ID: 15908995
[TBL] [Abstract][Full Text] [Related]
5. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
[TBL] [Abstract][Full Text] [Related]
6. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
Lachmann RH; Efstathiou S
Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases.
Jerusalinsky D; Baez MV; Epstein AL
J Physiol Paris; 2012 Jan; 106(1-2):2-11. PubMed ID: 22108428
[TBL] [Abstract][Full Text] [Related]
8. Multiple applications for replication-defective herpes simplex virus vectors.
Burton EA; Wechuck JB; Wendell SK; Goins WF; Fink DJ; Glorioso JC
Stem Cells; 2001; 19(5):358-77. PubMed ID: 11553845
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
10. Use of herpes simplex virus type 1 for transgene expression within the nervous system.
Lachmann RH; Efstathiou S
Clin Sci (Lond); 1999 Jun; 96(6):533-41. PubMed ID: 10334958
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy with herpes simplex virus vectors.
Latchman DS
Arch Immunol Ther Exp (Warsz); 1999; 47(6):335-40. PubMed ID: 10608288
[TBL] [Abstract][Full Text] [Related]
12. Use of HSV vectors to modify the nervous system.
Glorioso JC; Fink DJ
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):289-95. PubMed ID: 11926135
[TBL] [Abstract][Full Text] [Related]
13. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
Yang T; Wang X; Yan Z; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234
[TBL] [Abstract][Full Text] [Related]
14. Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo.
Dumas T; McLaughlin J; Ho D; Meier T; Sapolsky R
Gene Ther; 1999 Oct; 6(10):1679-84. PubMed ID: 10516716
[TBL] [Abstract][Full Text] [Related]
15. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
17. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
18. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus-based vectors.
Lachmann R
Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]